- United States
- /
- Food
- /
- NYSE:INGR
Ingredion Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
Ingredion (NYSE:INGR) Second Quarter 2025 Results
Key Financial Results
- Revenue: US$1.83b (down 2.4% from 2Q 2024).
- Net income: US$196.0m (up 32% from 2Q 2024).
- Profit margin: 11% (up from 7.9% in 2Q 2024). The increase in margin was driven by lower expenses.
- EPS: US$3.04 (up from US$2.25 in 2Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Ingredion EPS Beats Expectations, Revenues Fall Short
Revenue missed analyst estimates by 3.0%. Earnings per share (EPS) exceeded analyst estimates by 7.6%.
Looking ahead, revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 2.7% growth forecast for the Food industry in the US.
Performance of the American Food industry.
The company's shares are up 2.2% from a week ago.
Risk Analysis
Before you take the next step you should know about the 1 warning sign for Ingredion that we have uncovered.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NYSE:INGR
Ingredion
Engages in the manufacture and sale of sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries worldwide.
Very undervalued with flawless balance sheet and pays a dividend.
Similar Companies
Market Insights
Weekly Picks

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets
Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Investment Analysis (May 2026)
Recently Updated Narratives

Making sense of 1.75 trillion IPO
SpaceX? Only Fast in - Fast out!

INDIAN OIL CORPORATION IS THE TITAN IN TRANSITION
Popular Narratives

Investment Analysis (May 2026)

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Honeywell - The Demand-Side of the AI Infrastructure
Trending Discussion
